In last trading session, Seres Therapeutics Inc (NASDAQ:MCRB) saw 2.31 million shares changing hands with its beta currently measuring 2.00. Company’s recent per share price level of $0.75 trading at -$0.04 or -6.18% at ring of the bell on the day assigns it a market valuation of $112.92M. That closing price of MCRB’s stock is at a discount of -734.67% from its 52-week high price of $6.26 and is indicating a premium of 28.0% from its 52-week low price of $0.54. Taking a look at company’s average trading volume volume of 4.95 million if we extend that period to 3-months.
Seres Therapeutics Inc (NASDAQ:MCRB) trade information
Upright in the red during last session for losing -6.18%, in the last five days MCRB remained trading in the red while hitting it’s week-highest on Thursday, 06/06/24 when the stock touched $0.75 price level, adding 34.78% to its value on the day. Seres Therapeutics Inc’s shares saw a change of -46.74% in year-to-date performance and have moved -34.60% in past 5-day. Seres Therapeutics Inc (NASDAQ:MCRB) showed a performance of -22.74% in past 30-days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Seres Therapeutics Inc (MCRB) estimates and forecasts
Statistics highlight that Seres Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -25.21% of value to its shares in past 6 months, showing an annual growth rate of -15.73% while that of industry is 15.40. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.
Company posted 126.47M and 1.87M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 18.22% during past 5 years.
MCRB Dividends
Seres Therapeutics Inc is more likely to be releasing its next quarterly report in July and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
